Title: 
Official Title: 
Number of Sections: 1
Source: versions - sb526 sfat rucker _1 3-26 adopted.htm
Media Type: text/html

================================================================================

Section 1:
ï»¿ SB526 SFAT Rucker #1 3-26Dellinger  7965Senator Rucker moved to amend the bill by striking out the title and substituting therefor a new title, to read as follows:	Eng. Com. Sub. for Senate Bill 526—A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new article, designated §30-5A-1, §30-5A-2, §30-5A-3, and §30-5A-4, relating to creating the Pharmacist Prescribing Authority Act; authorizing pharmacists to prescribe low-risk medications to patients; listing the limitations of the prescriptions that fall under that authority; providing that pharmacist may notify the patient’s primary care physician, if identified, within 72 hours; limiting prescription dispensed or prescribed to a 30-day supply within a six-month timeframe; requiring the pharmacist to notify the primary care physician, if identified, if more than 10 days is prescribed or dispensed; and exempting addition to scope of pharmacy practice from sunrise review. AdoptedRejected


================================================================================

Raw Text:
ï»¿ SB526 SFAT Rucker #1 3-26Dellinger  7965Senator Rucker moved to amend the bill by striking out the title and substituting therefor a new title, to read as follows:	Eng. Com. Sub. for Senate Bill 526—A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new article, designated §30-5A-1, §30-5A-2, §30-5A-3, and §30-5A-4, relating to creating the Pharmacist Prescribing Authority Act; authorizing pharmacists to prescribe low-risk medications to patients; listing the limitations of the prescriptions that fall under that authority; providing that pharmacist may notify the patient’s primary care physician, if identified, within 72 hours; limiting prescription dispensed or prescribed to a 30-day supply within a six-month timeframe; requiring the pharmacist to notify the primary care physician, if identified, if more than 10 days is prescribed or dispensed; and exempting addition to scope of pharmacy practice from sunrise review. AdoptedRejected